Essential thrombocythaemia: Anagrelide or interferon-alfa? A cost-utility analysis

Tools

Wilson, E. ORCID: https://orcid.org/0000-0002-8369-1577 and Fordham, R. J. ORCID: https://orcid.org/0000-0002-5520-6255 (2006) Essential thrombocythaemia: Anagrelide or interferon-alfa? A cost-utility analysis. In: European Haematological Association, Amsterdam, 2006-01-01.

Full text not available from this repository. (Request a copy)

Item Type:	Conference or Workshop Item (Other)
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Health Economics Faculty of Medicine and Health Sciences > Research Centres > Population Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:08
Last Modified:	12 Jun 2024 15:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/12060
DOI:

View Item